Cargando…
Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling
BACKGROUND: Monolayer cultures of immortalised cell lines are a popular screening tool for novel anti-cancer therapeutics, but these methods can be a poor surrogate for disease states, and there is a need for drug screening platforms which are more predictive of clinical outcome. In this study, we d...
Autores principales: | Sandercock, Alan M., Rust, Steven, Guillard, Sandrine, Sachsenmeier, Kris F., Holoweckyj, Nick, Hay, Carl, Flynn, Matt, Huang, Qihui, Yan, Kuan, Herpers, Bram, Price, Leo S., Soden, Jo, Freeth, Jim, Jermutus, Lutz, Hollingsworth, Robert, Minter, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521473/ https://www.ncbi.nlm.nih.gov/pubmed/26227951 http://dx.doi.org/10.1186/s12943-015-0415-0 |
Ejemplares similares
-
Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type
por: Rust, Steven, et al.
Publicado: (2013) -
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy
por: Williams, Geoffrey S., et al.
Publicado: (2016) -
Targeting CD73 in the tumor microenvironment with MEDI9447
por: Hay, Carl M., et al.
Publicado: (2016) -
Improved drug-like properties of therapeutic proteins by directed evolution
por: Buchanan, Andrew, et al.
Publicado: (2012) -
We need to bring R0 < 1 to treat cancer too
por: Srikrishna, Devabhaktuni, et al.
Publicado: (2021)